Clearance Summary
Accipiolx received FDA 510(k) clearance under submission number K201310, sponsored by Maxq AL , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2020-08-07.
- Submission: K201310
- Applicant / Sponsor: Maxq AL , Ltd.
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.2080
- Decision date: 2020-08-07
Classification & Regulation
This clearance is catalogued under FDA product code QAS and 21 CFR 892.2080, within the Radiology review panel as a Class II device.